Long-acting Reversible Contraceptive (LARC)

Showing 25-32 of 43 results

Research roundup: October 2021 edition

Novel ulipristal-releasing copper IUD, internal medicine physicians’ provision of medication abortion in a primary care setting, analysis of contraceptive decision aids for adolescents and young adults, and more.

Research roundup: August 2021 edition

Provision of medication abortion via telehealth, updated CDC treatment guidelines for sexually-transmitted infections, barriers to IUD and implant access for adolescent and young adult patients, and more.

Research roundup: April 2021 edition

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Patient perspective: The three surprises of getting my IUD

It feels like everything that could have gone wrong with getting my IUD did.

Research roundup: March 2021 edition

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.

Research roundup: December 2020 edition

An analysis of the use of verbal anesthesia vs. oral tramadol for pain management in IUD placement, potential effectiveness of DMPA as a self-bridging emergency contraceptive, the importance of access to PrEP among people at risk of HIV infection through receptive vaginal intercourse, and more.

Research roundup: July 2020 edition

Society of Family Planning’s clinical recommendations for contraceptive counseling for transgender and gender-expansive patients, the positive effect of levonorgestrel IUDs on female sexual function, barriers to abortion care within religious hospital systems, and more.

Research roundup: June 2020 edition

Improved access to abortion care during the COVID-19 pandemic through implementation of a no-test protocol for medication abortion, use of Lactin-V in treatment of recurrent bacterial vaginosis, importance of expanded access to postpartum contraceptive options to improve both maternal and fetal outcomes, and more.
  • Previous
  • 2
  • 3
  • 4(current)
  • 5
  • 6
  • Next